Literature DB >> 14628856

Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity.

A Fredriksson, N Schröder, T Archer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14628856     DOI： 10.1007/bf03033373

Source DB:  PubMed          Journal:  Neurotox Res        ISSN： 1029-8428            Impact factor:   3.911


× No keyword cloud information.
  91 in total

1.  Milk and nutrient intake of breast-fed infants from 1 to 6 months: relation to growth and fatness.

Authors:  K G Dewey; B Lönnerdal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

2.  Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.

Authors:  H Mochizuki; H Imai; K Endo; K Yokomizo; Y Murata; N Hattori; Y Mizuno
Journal:  Neurosci Lett       Date:  1994-02-28       Impact factor: 3.046

3.  Alpha-phenyl-tert-butyl-nitrone (PBN) reverses age-related maze learning performance and motor activity deficits in C57 BL/6 mice.

Authors:  A. Fredriksson; T. Archer
Journal:  Behav Pharmacol       Date:  1996-05       Impact factor: 2.293

4.  NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.

Authors:  T Klockgether; L Turski
Journal:  Ann Neurol       Date:  1990-10       Impact factor: 10.422

5.  Frataxin gene of Friedreich's ataxia is targeted to mitochondria.

Authors:  J Priller; C R Scherzer; P W Faber; M E MacDonald; A B Young
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

Review 6.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Authors:  R E Heikkila; B A Sieber; L Manzino; P K Sonsalla
Journal:  Mol Chem Neuropathol       Date:  1989-06

7.  Iron-dependent enzymes in Parkinson's disease.

Authors:  H Reichmann; B Janetzky; P Riederer
Journal:  J Neural Transm Suppl       Date:  1995

8.  Neurobehavioral dysfunctions associated with dietary iron overload.

Authors:  T J Sobotka; P Whittaker; J M Sobotka; R E Brodie; D Y Quander; M Robl; M Bryant; C N Barton
Journal:  Physiol Behav       Date:  1996-02

9.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

10.  A histochemical study of iron-positive cells in the developing rat brain.

Authors:  J R Connor; G Pavlick; D Karli; S L Menzies; C Palmer
Journal:  J Comp Neurol       Date:  1995-04-24       Impact factor: 3.215
View more
  8 in total

1.  Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.

Authors:  A Fredriksson; P Eriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.575

2.  Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurochem Res       Date:  2007-08-12       Impact factor: 3.996

3.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

4.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

5.  Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 6.  Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: a systematic review.

Authors:  Sonal Agrawal; Kiersten L Berggren; Eileen Marks; Jonathan H Fox
Journal:  Nutr Rev       Date:  2017-06-01       Impact factor: 7.110

Review 7.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

Review 8.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.